Skip to main content
The Bright Side
arrow_backHome
FDA approves new drug Rasonque to treat advanced pancreatic cancer
Community
France 24 HealthEN
August 26, 2026

FDA approves new drug Rasonque to treat advanced pancreatic cancer

The US FDA on Wednesday approved Revolution Medicines' Rasonque for advanced pancreatic cancer, opening a new treatment option for patients with metastatic disease. A large trial found the once-daily pill doubled survival rates, offering fresh hope for people who have exhausted other treatments.

Read More

Curated from France 24 Health. Classified as Community by AI, which sometimes makes mistakes.

Why are you reporting this article?

Why are you reporting this article?
0/500

More like this

More